Absci Corp (ABSI NASDAQ) stock market data APIs
$7.1635
0.24(3.4%)
as of July 28, 2026
Try our APIs with
free plan!
Absci Corp Financial Data Overview
Price chart is built with
Anychart
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Prev. Close
7.1635
Open
7.4049
High
7.439
Low
6.8567
52 wk Range
2.24-12.055
Market Cap
1 281 M
Shares Outstanding
169 M
Revenue
1 836 K
EPS
-0.19
Beta
2.33
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Absci Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Absci Corp data using free add-ons & libraries
Get Absci Corp Fundamental Data
Absci Corp Fundamental data includes:
- Net Revenue: 1 836 K
- EBITDA: -116 437 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.2
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Absci Corp News
New
Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify
Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off pos...
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
Issued on behalf of MindWalk Holdings Corp. (NASDAQ: HYFT) AUSTIN, Texas, July 24, 2026 /PRNewswire/ -- American News Group News Commentary - The race to bring artificial intelligence into drug disco...
Cathie Wood makes $20.5M bet on sliding tech stock
SpaceX (SPCX) investors are reeling after a brutal sell-off. The stock has comfortably slipped below its $135 IPO price, according to Yahoo Finance, facing concerns over Starship delays, an incredibl...
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
We expect investors to focus on updates related to Viking Therapeutics' VKTX pipeline when it reports second-quarter 2026 earnings. In the last reported quarter, the company's earnings missed expectat...
Get Absci Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
